Whither Science Publishing?

As we stand on the brink of a new scientific age, how researchers should best communicate their findings and innovations is hotly debated in the publishing trenches.

Written byThe Scientist
| 18 min read

Register for free to listen to this article
Listen with Speechify
0:00
18:00
Share

Scholarly publishing is, and always has been, an adaptable beast. What started as the hand-scribed musings of ancient philosophers evolved into the printed manuscripts of wealthy gentlemen-scientists observing nature or conducting experiments using their own pounds sterling. These “natural philosophers” formed the Royal Society of London for Improving Natural Knowledge in the mid-17th century and published their work in the Philosophical Transactions of the Royal Society, the first journal devoted entirely to science and one that continues to publish biweekly issues to this day.

Over the intervening centuries, academic publishing has morphed into a sprawling international industry that, on the one hand, rakes in revenues of more than $19 billion in its scientific, technical, and medical segment alone, according to one 2008 analysis (Electronic Journal of Academic and Special Librarianship, 9, ISSN 1704-8532, 2008). On the other hand, a constellation of open-access (OA) publishers, producing nearly 8,000 OA journals (according ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies